OTC Movers: Autodesk, Inc. (NASDAQ:ADSK), Caesars Entertainment Corp (NASDAQ:CZR), Halozyme Therapeutics, Inc. (NASDAQ:HALO), Health Care REIT, Inc. (NYSE:HCN)

Lakeway, NY -- (SBWIRE) -- 02/26/2013 -- ThePennyStockProfiler.com, an investment community with a special focus on updating investors with recent news on the U.S. stock market, issues news alert on the following stocks:-

Autodesk, Inc. (NASDAQ:ADSK) moved down 2.24% to $35.80 after market trading hours. The Company reported fourth quarter non-GAAP EPS of $0.53 from $0.46 in the prior year period. Revenue was $607 million, an increase of 2% from a year ago. The consensus estimates were for EPS of $0.49 and revenues of $586.16 million. The company expects to report first quarter non-GAAP EPS of $0.41 to $0.46. The consensus estimate is for EPS of $0.51.

Is ADSK a Still a Buy after the Solid momentum? Let’s Find out Here

Caesars Entertainment Corp (NASDAQ:CZR) declined 7.51% to $10.83 after market trading hours. The Company reported a net loss for the fourth quarter of $469.7 million or $3.75 per share compared to net loss of $220.6 or $1.76 per share in the year-ago quarter. Fourth quarter revenues declined 4.3% to $2.02 billion from $2.11 billion a year ago. The analysts polled by Thomson Reuters expected the company to report a loss of $2.04 per share on revenue of $2.11 billion for the fourth quarter.

Is CZR a Strong Buying Opportunity After The Recent Gain? Find out Here

Halozyme Therapeutics, Inc. (NASDAQ:HALO) closed at $5.72. The Company posted fourth quarter net loss of $4.4 million or $0.04 per share compared to $18.4 million or $0.18 per share in the year ago period. The analysts polled by Thomson Reuters expected the company to report a loss of $0.15 per share. Operating loss for the quarter narrowed to $4.42 million from $18.43 million in previous year quarter. Total revenues for the current fourth quarter soared to $21.79 million from $2.41 million in the comparable quarter last year.

Should HALO Buy After The Recent Movement? Let’s Find out Here

Health Care REIT, Inc. (NYSE:HCN) closed at $63.19. The Company reported fourth quarter 2012 normalized FFO and FAD of $0.85 and $0.74 per share. The same-store cash NOI increased by 4.0%.

The Company generated 2012 total shareholder return of 18%. The Company expanded internationally with investments in Canada and the United Kingdom. The Company Completed gross new investments of $2.0 billion in 4Q12.

Should HCN Buy After The Recent Movement? Let’s Find out Here

About ThePennyStockProfiler.com
ThePennyStockProfiler.com is engaged in providing the most up to date and useful information on Microcap Stocks poised to breakout. ThePennyStockProfiler.com also provides investors with trend analysis, detailed company profiles, and most importantly a much needed "informational edge" which can be used as a tool for making investment decisions. To Receive Instant updates in the inbox, readers are advised to sign up for free at http://www.ThePennyStockProfiler.com

Disclaimer
The assembled information disseminated by ThePennyStockProfiler.com is for information purposes only, and is neither a solicitation to buy nor an offer to sell securities. ThePennyStockProfiler.com does expect that investors will buy and sell securities based on information assembled and presented in phd-trading.com. PLEASE always do your own due diligence, and consult your financial advisor.